Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $9.48 Million - $12.5 Million
235,500 Added 70.83%
568,000 $23.6 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $11.7 Million - $13.3 Million
244,300 Added 276.98%
332,500 $18 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $1.1 Million - $1.31 Million
22,600 Added 34.45%
88,200 $4.53 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $1.87 Million - $2.08 Million
-29,400 Reduced 30.95%
65,600 $4.2 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $2.16 Million - $2.45 Million
-32,900 Reduced 25.72%
95,000 $6.58 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $1.01 Million - $1.2 Million
14,800 Added 13.09%
127,900 $9.2 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $7,800 - $4.61 Million
-60,000 Reduced 34.66%
113,100 $8.04 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $4.37 Million - $4.81 Million
60,200 Added 53.32%
173,100 $13.3 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $14.3 Million - $17.1 Million
-232,100 Reduced 67.28%
112,900 $8.25 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $10,726 - $12,504
-200 Reduced 0.06%
345,000 $21.5 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $15.2 Million - $17.8 Million
257,400 Added 293.17%
345,200 $20.4 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $2.2 Million - $2.39 Million
-35,500 Reduced 28.79%
87,800 $5.87 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $3.86 Million - $4.34 Million
-65,000 Reduced 34.52%
123,300 $7.78 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $10.7 Million - $12.1 Million
184,700 Added 5130.56%
188,300 $11.7 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $93,499 - $121,961
-1,900 Reduced 34.55%
3,600 $231,000
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $235,235 - $278,905
5,500 New
5,500 $279,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.